Lucid Diagnostics Inc.

NasdaqCM:LUCD Stock Report

Market Cap: US$139.6m

Lucid Diagnostics Management

Management criteria checks 3/4

Lucid Diagnostics' CEO is Lishan Aklog, appointed in Oct 2021, has a tenure of 3.67 years. total yearly compensation is $712.00K, comprised of 42.1% salary and 57.9% bonuses, including company stock and options. directly owns 1.36% of the company’s shares, worth $1.89M. The average tenure of the management team and the board of directors is 3.5 years and 4.5 years respectively.

Key information

Lishan Aklog

Chief executive officer

US$712.0k

Total compensation

CEO salary percentage42.13%
CEO tenure3.7yrs
CEO ownership1.4%
Management average tenure3.5yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

author-image

Expanded Reimbursement And Cash-Pay Programs Will Open Future Markets

Expanding reimbursement coverage and leveraging NCCN guidelines are strategies expected to enhance revenue and credibility with payers.

We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

May 09
We're A Little Worried About Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely

Dec 15
Lucid Diagnostics (NASDAQ:LUCD) Will Have To Spend Its Cash Wisely

Lucid Diagnostics launches stage II lucid test center in California, Texas, Florida, and Ohio

Aug 11

We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

Jul 07
We're Keeping An Eye On Lucid Diagnostics' (NASDAQ:LUCD) Cash Burn Rate

CEO Compensation Analysis

How has Lishan Aklog's remuneration changed compared to Lucid Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2025n/an/a

-US$71m

Dec 31 2024US$712kUS$300k

-US$53m

Sep 30 2024n/an/a

-US$52m

Jun 30 2024n/an/a

-US$54m

Mar 31 2024n/an/a

-US$55m

Dec 31 2023US$300kUS$300k

-US$53m

Sep 30 2023n/an/a

-US$57m

Jun 30 2023n/an/a

-US$57m

Mar 31 2023n/an/a

-US$60m

Dec 31 2022US$456kn/a

-US$56m

Sep 30 2022n/an/a

-US$53m

Jun 30 2022n/an/a

-US$45m

Mar 31 2022n/an/a

-US$37m

Dec 31 2021US$7mn/a

-US$28m

Compensation vs Market: Lishan's total compensation ($USD712.00K) is about average for companies of similar size in the US market ($USD641.60K).

Compensation vs Earnings: Lishan's compensation has increased whilst the company is unprofitable.

CEO

Lishan Aklog (59 yo)

3.7yrs
Tenure
US$712,000
Compensation

Dr. Lishan Aklog, M.D., serves as an Executive Chairman at Veris Health Inc. since April 2023. He served as Independent Director at ContraFect Corporation since June 14, 2020 until December 04, 2023. Dr. A...

Leadership Team

NamePositionTenureCompensationOwnership
Lishan Aklog
Chairman & CEO3.7yrsUS$712.00k1.36%
$ 1.9m
Shaun O'Neill
President & COO3.3yrsUS$712.00k0.76%
$ 1.1m
Dennis McGrath
Chief Financial Officer7.1yrsUS$637.00k1.24%
$ 1.7m
Michael Gordon
General Counsel & Secretary3.1yrsUS$662.00k0.65%
$ 903.0k
Sanford Markowitz
Co-Founder & Strategic Advisorno dataUS$924.54kno data
Joseph Willis
Co-founder & Strategic Advisorno datano datano data
Amitabh Chak
Co-Founder & Strategic Advisorno datano datano data
Helen Moinova
Co-Founder & Strategic Advisorno datano datano data
Brian deGuzman
Chief Technology & Compliance Officerno datano datano data
Suman Verma
Chief Scientific Officer3.7yrsno datano data
Matthew Riley
Director of Investor Relationsno datano datano data
Deepika Lakhani
Senior VP1.3yrsno datano data
3.5yrs
Average Tenure
59yo
Average Age

Experienced Management: LUCD's management team is considered experienced (3.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Lishan Aklog
Chairman & CEO7.1yrsUS$712.00k1.36%
$ 1.9m
Stanley Lapidus
Independent Vice Chairman of the Board & Lead Independent Director3.9yrsUS$188.31k0.20%
$ 276.6k
Ronald Sparks
Independent Director3.7yrsUS$235.81k0.18%
$ 254.7k
Jacque Sokolov
Independent Director4.2yrsUS$225.81k0.18%
$ 254.7k
Dennis Matheis
Independent Director1.1yrsUS$205.26k0.52%
$ 729.4k
James Cox
Independent Director7.1yrsUS$199.62k0.26%
$ 363.9k
Debra White
Independent Director2.8yrsUS$205.81k0.10%
$ 145.5k
Nicholas Shaheen
Chair of Medical Advisory Board7.1yrsno datano data
Michael Smith
Member of Medical Advisory Board7.1yrsno datano data
Srinadh Komanduri
Member of Medical Advisory Board4.9yrsno datano data
Stuart Spechler
Member of Medical Advisory Boardno datano datano data
Rhonda Souza
Member of Medical Advisory Boardno datano datano data
4.5yrs
Average Tenure
70yo
Average Age

Experienced Board: LUCD's board of directors are considered experienced (4.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/06/09 03:28
End of Day Share Price 2025/06/06 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Lucid Diagnostics Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward WooAscendiant Capital Markets LLC
Mark MassaroBTIG
Kyle MiksonCanaccord Genuity